CN1314813A - 新的异噁唑啉酮抗菌剂 - Google Patents

新的异噁唑啉酮抗菌剂 Download PDF

Info

Publication number
CN1314813A
CN1314813A CN99809894A CN99809894A CN1314813A CN 1314813 A CN1314813 A CN 1314813A CN 99809894 A CN99809894 A CN 99809894A CN 99809894 A CN99809894 A CN 99809894A CN 1314813 A CN1314813 A CN 1314813A
Authority
CN
China
Prior art keywords
alkyl
optional
phenyl
alkoxyl
replaces
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99809894A
Other languages
English (en)
Chinese (zh)
Inventor
L·B·斯尼德尔
Z·郑
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CN1314813A publication Critical patent/CN1314813A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN99809894A 1998-08-24 1999-08-23 新的异噁唑啉酮抗菌剂 Pending CN1314813A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9757498P 1998-08-24 1998-08-24
US60/097574 1998-08-24

Publications (1)

Publication Number Publication Date
CN1314813A true CN1314813A (zh) 2001-09-26

Family

ID=22264103

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99809894A Pending CN1314813A (zh) 1998-08-24 1999-08-23 新的异噁唑啉酮抗菌剂

Country Status (22)

Country Link
EP (1) EP1107756A4 (es)
JP (1) JP2002523369A (es)
KR (1) KR20010072945A (es)
CN (1) CN1314813A (es)
AR (1) AR020250A1 (es)
AU (1) AU748750B2 (es)
BR (1) BR9913225A (es)
CA (1) CA2341271A1 (es)
CO (1) CO5160266A1 (es)
CZ (1) CZ2001669A3 (es)
HU (1) HUP0103433A3 (es)
ID (1) ID27690A (es)
IL (1) IL141542A0 (es)
NO (1) NO20010916L (es)
NZ (1) NZ509867A (es)
PE (1) PE20001063A1 (es)
PL (1) PL346267A1 (es)
TR (1) TR200100672T2 (es)
TW (1) TW572757B (es)
UY (1) UY25677A1 (es)
WO (1) WO2000010566A1 (es)
ZA (1) ZA200101505B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110423610A (zh) * 2019-08-29 2019-11-08 浙江理工大学 一种检测双光子汞离子荧光探针及其制备方法与使用方法

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465456B2 (en) 2000-06-29 2002-10-15 Bristol-Myers Squibb Company Isoxazolinone antibacterial agents
JP2002020366A (ja) * 2000-07-05 2002-01-23 Sumitomo Seika Chem Co Ltd アルキルチオフェニル酢酸類の製造方法
PE20020689A1 (es) 2000-11-17 2002-08-03 Upjohn Co Oxazolidinonas con un heterociclo de 6 o 7 miembros unidos con enlace anular al benceno
PE20030044A1 (es) 2000-11-17 2003-02-09 Upjohn Co Isoxazolinonas biciclicas de formula i
US6861433B2 (en) * 2000-12-15 2005-03-01 Pharmacia & Upjohn Company Oxazolidinone photoaffinity probes
JP2004518677A (ja) 2000-12-21 2004-06-24 ファルマシア・アンド・アップジョン・カンパニー 抗菌性キノロン誘導体および細菌感染を治療するためのその使用
ES2180456B1 (es) * 2001-07-20 2004-05-01 Laboratorios S.A.L.V.A.T., S.A. Isoxazoles sustituidos y su utilizacion como antibioticos.
WO2003031443A1 (en) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
WO2003035073A1 (en) 2001-10-25 2003-05-01 Astrazeneca Ab Isoxazoline derivatives useful as antimicrobials
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
WO2004033449A1 (en) * 2002-10-10 2004-04-22 Pharmacia & Upjohn Company Llc Antimicrobial 1-aryl dihydropyridone compounds
JP2006516991A (ja) * 2003-02-07 2006-07-13 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 抗菌剤
DE602004014361D1 (de) 2003-04-30 2008-07-24 Morphochem Ag Komb Chemie Verwendung von oxazolidinon-chinolin-hybrid-antibiotika zur behandlung von anthrax und anderen infektionen
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
WO2005070904A2 (en) * 2003-06-03 2005-08-04 Rib-X Pharmaceutical, Inc. Sulfonamide compounds and methods of making and using the same
US6969726B2 (en) 2003-06-03 2005-11-29 Rib X Pharmaceuticals Inc Biaryl heterocyclic compounds and methods of making and using the same
WO2005012270A2 (en) * 2003-07-29 2005-02-10 Rib-X Pharmaceuticals, Inc. Biaryl heterocyclic amines, amides, and sulfur-containing compounds and methods of making and using the same
DE10340485B4 (de) * 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
JP2007514782A (ja) 2003-12-17 2007-06-07 リブ−エックス ファーマシューティカルズ,インコーポレイテッド ハロゲン化ビアリール複素環式化合物ならびにその作製方法および使用方法
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
ATE401326T1 (de) 2003-12-18 2008-08-15 Morphochem Ag Komb Chemie Oxazolidinon-chinolon hybrid antibiotika
WO2005082900A2 (en) * 2004-01-28 2005-09-09 Pharmacia & Upjohn Company Llc Oxazolidinone amidoximes as antibacterial agents
KR101394307B1 (ko) 2005-06-08 2014-05-13 멜린타 테라퓨틱스, 인크. 트리아졸의 합성 방법
AT503354B1 (de) * 2006-02-22 2008-07-15 Dsm Fine Chem Austria Gmbh Verfahren zur herstellung von 3,4-disubstituierten phenylessigsäuren, sowie neue zwischenverbindungen
JP4518066B2 (ja) * 2006-10-25 2010-08-04 宇部興産株式会社 ジアルコキシニトリル誘導体及びその製法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2045049A1 (de) * 1970-09-11 1972-03-23 Dr Karl Thomae GmbH, 7950 Biberach Neue Nitrofurandenvate und Ver fahren zu ihrer Herstellung
US4000155A (en) * 1975-12-11 1976-12-28 Eli Lilly And Company Herbicidal 2-methyl-4-phenyl-5-pyrazolinones[and isoxazolinones]
ES2111188T3 (es) * 1992-12-08 1998-03-01 Upjohn Co Agentes antibacterianos derivados de feniloxazolidinona sustituida con tropona.
AU6902096A (en) * 1995-09-15 1997-04-01 Pharmacia & Upjohn Company 5-amidomethyl alpha, beta-saturated and -unsaturated 3-aryl butyrolactone antibacterial agents
GB9521508D0 (en) * 1995-10-20 1995-12-20 Zeneca Ltd Chemical compounds
PT920421E (pt) * 1996-08-21 2003-03-31 Upjohn Co Derivados de isoxazolina uteis como agentes antimicrobianos

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110423610A (zh) * 2019-08-29 2019-11-08 浙江理工大学 一种检测双光子汞离子荧光探针及其制备方法与使用方法
CN110423610B (zh) * 2019-08-29 2023-05-12 浙江理工大学 一种检测双光子汞离子荧光探针及其制备方法与使用方法

Also Published As

Publication number Publication date
NO20010916D0 (no) 2001-02-23
CO5160266A1 (es) 2002-05-30
ID27690A (id) 2001-04-19
WO2000010566A1 (en) 2000-03-02
AU748750B2 (en) 2002-06-13
AU5783399A (en) 2000-03-14
ZA200101505B (en) 2002-02-22
PE20001063A1 (es) 2000-12-24
UY25677A1 (es) 2001-08-27
HUP0103433A2 (hu) 2002-01-28
CA2341271A1 (en) 2000-03-02
KR20010072945A (ko) 2001-07-31
NO20010916L (no) 2001-04-10
PL346267A1 (en) 2002-01-28
AR020250A1 (es) 2002-05-02
BR9913225A (pt) 2001-05-22
TR200100672T2 (tr) 2001-07-23
JP2002523369A (ja) 2002-07-30
IL141542A0 (en) 2002-03-10
EP1107756A4 (en) 2003-02-26
NZ509867A (en) 2003-08-29
CZ2001669A3 (cs) 2001-08-15
HUP0103433A3 (en) 2002-08-28
EP1107756A1 (en) 2001-06-20
TW572757B (en) 2004-01-21

Similar Documents

Publication Publication Date Title
CN1314813A (zh) 新的异噁唑啉酮抗菌剂
CN1170827C (zh) 苯并呋喃基吡喃酮衍生物
CN1093124C (zh) 对PPAR-γ具有激动剂活性的取代的4-羟基-苯基alcanoic acid衍生物
CN1267431C (zh) 取代的喹唑啉衍生物及其在制备作为抑制剂的药物中的用途
CN1308310C (zh) 含氮芳环衍生物
CN1101380C (zh) 作为法尼基转移酶抑制剂的4-巯基吡咯烷衍生物
CN1252057C (zh) 用于治疗与paar有关的疾病的噻唑衍生物
CN1269820C (zh) 作为药物的新的吡咯衍生物
CN1269813C (zh) 作为细胞增生抑制剂的咪唑-5-基-2-苯胺基-嘧啶
CN1277829C (zh) 具有抗生素活性的3,5-二取代-1,3-噁唑烷-2-酮,其制备方法和用途
CN1264846C (zh) 作为糖原磷酸化酶抑制剂的双环吡咯基酰胺类化合物
CN1165534C (zh) 作为抗菌剂的杂环氨基甲基噁唑烷酮
CN1946666A (zh) 用于治疗代谢性疾病的化合物、药物组合物和方法
CN1118457C (zh) 新的环状二胺化合物及含有它的药物
CN1196703C (zh) 作为cdk2抑制剂的吡唑并苯并二氮䓬
CN1414951A (zh) 药剂排出泵抑制药
CN1897936A (zh) 环状胍、含有这种化合物的组合物及其使用方法
CN1863779A (zh) 新型吲唑衍生物
CN1993361A (zh) 用于治疗与血管发生有关的高增生性病症和疾病的吡咯并三嗪衍生物
CN1993124A (zh) 取代吡唑、含有这种化合物的组合物及其应用
CN1882572A (zh) 作为抗肿瘤药物的喹唑啉衍生物
CN1549817A (zh) 作为半胱氨酸蛋白酶抑制剂的吡咯并嘧啶化合物
CN1852905A (zh) 具有n-取代的苯并咪唑基的c-kit抑制剂
CN1197457A (zh) 以c-c键连接于4-8元杂环环的苯基唑烷酮
CN1659144A (zh) 喹啉和异喹啉衍生物、其制备方法以及作为炎症抑制剂的应用

Legal Events

Date Code Title Description
C06 Publication
C10 Entry into substantive examination
PB01 Publication
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication